How Inflammatory Disease Patients Respond to the COVID-19 Vaccine: What a Small Study Shows About Antibody Levels and Disease Flares
In one of the first studies to look at the impact of mRNA COVID-19 vaccines on people with chronic inflammatory diseases, researchers found patients were able to produce a sufficient amount of antibodies with relatively minimal side effects.
Continue reading